J. Boué

P. Moorhead, S. Plotkin, J. Boué, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Variation in argininosuccinate synthetase activity in amniotic fluid cell cultures: implications for prenatal diagnosis of citrullinemia.

V. Shih, J. Boué, M. Niermeijer, 1981, Clinica chimica acta; international journal of clinical chemistry.

In vitro cultivation of cells from aneuploid human embryos. Initiation of cell lines and longevity of the cultures

J. Boué, A. Boué, S. Cure, 1975, In Vitro.

[Prenatal diagnosis: results of 1530 amniotic taps and prospective study of 1023 cases (author's transl)].

J. Boué, A. Boué, I. Morer, 1979, La Nouvelle presse medicale.

Genetic Counselling and Prenatal Diagnosis for Chromosome Anomalies

J. Boué, A. Boué, 1976, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[Identification by Q and G bands of chromosome anomalies in spontaneous abortion].

J. Boué, A. Boué, N. Ravisé, 1976, Annales de genetique.

[Spontaneous abortion in women: cytogenetic and epidemiological studies].

J. Boué, A. Boué, 1973, Revue francaise de gynecologie et d'obstetrique.

Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid.

J. Fiet, H. Galons, M. Raux-Demay, 1988, The Journal of clinical endocrinology and metabolism.

Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses

A. Durandy, J. Boué, Y. Dumez, 1987, Prenatal diagnosis.

More precise localization of the gene for Hunter syndrome.

J. Boué, I. Oberlé, P. Couillin, 1990, Genomics.

Clastogen-induced chromosomal breakage as a marker for first trimester prenatal diagnosis of Fanconi anemia

A. Auerbach, E. Pergament, Y. Verlinsky, 1986, Human Genetics.

Amniotic fluid GGT and congenital extrahepatic biliary damage

J. Boué, F. Gauthier, J. Laurent, 1991, The Lancet.

Identification of C trisomies in human abortuses.

J. Boué, A. Boué, C. Deluchat, 1975, Journal of medical genetics.

Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes.

J. Mandel, C. Kretz, J. Boué, 1993, American journal of human genetics.

Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development.

J. Mandel, V. Biancalana, F. Rousseau, 1992, American journal of medical genetics.

[Human cell lines with chromosome aberrations (trisomy, monosomy and triploid cells), karyotype stability and longevity].

J. Boué, A. Boué, É. Deshayes, 1968, Pathologie et biologie.

Evidence for two active X chromosomes in a human XXY triploid

S. Gartler, J. Boué, A. Boué, 1975, Human Genetics.

General Cystic Fibrosis Mutations Are Usually Missense Mutations Affecting Two Specific Protein Domains and Associated with a Specific RFLP Marker Haplotype

J. Boué, A. Boué, B. Simon‐Bouy, 1993, European journal of human genetics : EJHG.

GENETIC DIFFERENCES BETWEEN CYSTIC FIBROSIS WITH AND WITHOUT MECONIUM ILEUS

X. Estivill, M. Farrall, R. Williamson, 1988, The Lancet.

Prenatal losses of trisomy 21.

J. Boué, A. Boué, H. Nicolas, 1981, Human genetics. Supplement.

Prenatal diagnosis of mucolipidosis type II on first‐trimester amniotic fluid

J. Oury, C. Mézard, J. Boué, 1990, Prenatal diagnosis.

First Trimester Prenatal Diagnosis of Metabolic Diseases

F. Thépot, J. Boué, L. Poenaru, 1985 .

ANTENATAL DIAGNOSIS OF COMBINED XANTHINE AND SULPHITE OXIDASE DEFICIENCIES

S. K. Wadman, J. Johnson, J. Saudubray, 1983, The Lancet.

Glycine/serine ratio and the prenatal diagnosis of non‐ketotic hyperglycinaemia

D. Rabier, P. Parvy, P. Kamoun, 1990, Prenatal diagnosis.

Prenatal diagnosis of argininosuccinic aciduria by assay of argininosuccinate in amniotic fluid at the 12th week of gestation.

D. Rabier, P. Kamoun, J. Desgrès, 1990, American journal of medical genetics.

The structural gene for aldolase B (ALDB) maps to 9q13→32

C. Junien, D. Weil, M. Mattei, 1985, Annals of human genetics.

[Molecular diagnosis of Duchenne and Becker muscular dystrophies. Current data].

C. Junien, J. Boué, A. Boué, 1987, Annales de genetique.

Prenatal diagnosis in 100 structural rearrangements of the chromosomes.

J. Boué, A. Boué, 1978, Cytogenetics and cell genetics.

PK3: A new chromosome enzyme marker for gene dosage studies in chromosome 15 imbalance

C. Junien, J. Boué, A. Boué, 2004, Human Genetics.

Unexpected structural chromosome rearrangements in prenatal diagnosis

F. Thépot, J. Boué, A. Boué, 1982, Prenatal diagnosis.

Ultrasound movement patterns of fetuses with chromosome anomalies

J. Boué, J. Boué, P. Vignal, 1982 .

Duplication 15q22»15qter and its phenotypic expression

C. Junien, C. Pernot, J. Boué, 2004, Human Genetics.

Molecular analysis of a ring chromosome X in a family with fragile X syndrome

E. Leguern, M. Mathieu, F. Thépot, 1993, Human Genetics.

Transition from Normal to Premutated Alleles in Fragile X Syndrome Results from a Multistep Process

J. Boué, A. Boué, B. Simon‐Bouy, 1994, European journal of human genetics : EJHG.

[Autoradiographic study of 2 familial t(DqDq) translocations].

B. Dutrillaux, I. Emerit, J. Lejeune, 1969, Annales de genetique.

Effects of rubella virus infection on the division of human cells.

J. Boué, A. Boué, 1969, American journal of diseases of children.

The structural gene for transferrin (TF) maps to 3q21----3qter.

K. Grzeschik, C. Junien, D. Weil, 1984, Annales de genetique.

[Chromosomal and anatomic studies of pregnancies after discontinuation of steroid contraceptives].

J. Boué, A. Boué, 1973, Journal de gynecologie, obstetrique et biologie de la reproduction.

Improved method for the antenatal diagnosis of citrullinemia.

P. Kamoun, J. Saudubray, J. Boué, 1981, Clinica chimica acta; international journal of clinical chemistry.

Gene for nonspecific X-linked mental retardation (MRX 47) is located in Xq22.3-q24.

P. Billuart, G. Ponsot, J. Chelly, 1997, American journal of medical genetics.

[Chromosome aberrations in spontaneous human abortions].

J. Boué, A. Boué, 1966, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.

Chromosome structural rearrangements and reproductive failure

J. Boué, A. Boué, 1981 .

[Evaluation of chromosome errors at the moment of conception].

J. Boué, A. Boué, 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

PMA 2016 / Nigeria. Performance Monitoring and Accountability 2020. Key family planning indicators.

A. Awasthi, C. Weisman, D. Elashoff, 2016 .

POLYMORPHIC DNA MARKERS IN PRENATAL DIAGNOSIS OF FRAGILE X SYNDROME

J. Mandel, M. Mattei, J. Boué, 1985, The Lancet.

Genetic Analysis of the Fragile X-Mental Retardation Syndrome with Polymorphic DNA Markers

M. Mattéi, G. Camerino, B. Arveiler, 1986 .

DNA polymorphism analysis in families with recurrence of free trisomy 21.

S. Antonarakis, C. Talbot, M. Rethoré, 1992, American journal of human genetics.

Nine mutations in the cystic fibrosis (CF) gene account for 80% of the CF chromosomes in French patients

J. Boué, A. Boué, B. Simon‐Bouy, 1991, Clinical genetics.

[HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].

J. Oury, J. Hors, J. Boué, 1987, Annales de Genetique.

[Trophoblastic gestational diseases. Triploid syndrome, perivillous trophoblastic hyperplasia, trophoblastic pseudotumor, trophoblastic microcarcinoma and carcinoma].

J. Boué, A. Boué, E. Philippe, 1980, Annales d'anatomie pathologique.

Nearly 80% of cystic fibrosis heterozygotes and 64% of couples at risk may be detected through a unique screening of four mutations by ASO reverse dot blot.

J. Boué, A. Boué, B. Simon‐Bouy, 1991, Genomics.

The meiotic behavior of triploidy in a human 69,XXX fetus.

J. Luciani, M. Devictor, J. Boué, 1978, Cytogenetics and Cell Genetics.

Three families with high expression of a fragile site at Xq27.3, lack of anomalies at the FMR-1 CpG island, and no clear phenotypic association.

J. Mandel, M. Mattei, J. Boué, 1992, American journal of medical genetics.

Direct DNA analysis of fragile X syndrome in Spanish pedigrees.

J. Mandel, V. Biancalana, J. Boué, 1992, American journal of medical genetics.

[Distribution of blood groups in Iran].

J. Boué, A. Boué, 1955, Le Sang.

Evidence for the presence of β-subunit of hexosaminidase in a case of Sandhoff disease using a blotting technique

J. Boué, L. Poenaru, S. Gautron, 2004, Human Genetics.

[Human viruses an chromosomes].

J. Boué, A. Boué, 1968, Pathologie et biologie.

Prenatal diagnosis of a heterozygote for mucopolysaccharidosis type VII (β‐glucuronidase deficiency)

J. Boué, L. Poenaru, J. Mossman, 1982, Prenatal diagnosis.

The cystic fibrosis ΔF508 mutation in the French population

J. Boué, A. Boué, B. Simon‐Bouy, 1990, Human Genetics.